Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tretinoin for large-scale oral leukoplakia
ChiCTR2300078212Phase 4Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in leukoplakia comparing Experimental group (immediate tretinoin) with Delayed treatment group (placebo then tretinoin) (2 arms). Primary endpoint: Efficacy rate at week 12. Started Dec 2023; status: recruiting.
02
Drugs
tretinoin
03
Conditions
leukoplakia
Beyond the preview
Go deeper on ChiCTR2300078212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078212.